Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of CYP3A4*1G Polymorphism on Non-analgesic Effects of Fentanyl in Chinese Han Patients

NCT03869346 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03869346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03869346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of CYP3A4*1G Polymorphism on Non-analgesic Effects of Fentanyl in Chinese Han Patients
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 10, 2019
Completion date
May 20, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fentanyl